Literature DB >> 2302061

Occult breast cancer presenting with axillary metastases. Updated management.

P L Baron1, M P Moore, D W Kinne, F C Candela, M P Osborne, J A Petrek.   

Abstract

An isolated axillary lymph node metastasis in a woman without an obvious clinical primary site most frequently originates from the breast. Mastectomy has been the historical treatment of choice. A retrospective study of 35 patients was undertaken to evaluate the roles of modern mammography, breast preservation, and adjuvant systemic therapy in the management of these patients. Twenty-eight patients underwent a mastectomy, while 7 were managed by a combination of limited resection and/or axillary dissection and radiation therapy. Twenty-two (67%) of the 33 breast specimens contained carcinoma. Comparison of the pathologic results with the preoperative mammograms showed a specificity of 73%, while the sensitivity was only 29%. Actuarial 5-year survival after mastectomy or breast preservation was similar (77% and 65%, respectively). Patients with more than one positive lymph node benefited from adjuvant therapy. Mammography does not locate the majority of occult stage II breast cancers, and both breast preservation and adjuvant therapy may have roles in the management of these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2302061     DOI: 10.1001/archsurg.1990.01410140088014

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  23 in total

1.  Occult Breast Cancer: A Case Report and Review of the Literature.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Clinicopathological Characteristics of Non-palpable Breast Cancer Presenting as Axillary Mass.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

Review 3.  Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola M Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Donna B Jeffe; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2013-08-22       Impact factor: 5.344

4.  Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.

Authors:  Hirofumi Asakura; Hitoshi Takashima; Masahiro Mitani; Reiji Haba; Reiko Seo; Koiku Yokoe; Yoshihiro Toyama; Motoomi Ohkawa
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

Review 5.  [Metastases with CUP syndrome].

Authors:  S Seeber; D Strumberg
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

6.  Occult breast cancers manifesting as axillary lymph node metastasis in men: a two-case report.

Authors:  Sung Mo Hur; Dong Hui Cho; Se Kyung Lee; Min-Young Choi; Soo Youn Bae; Min Young Koo; Sangmin Kim; Seok-Jin Nam; Jeong Eon Lee; Jung-Hyun Yang
Journal:  J Breast Cancer       Date:  2012-09-28       Impact factor: 3.588

7.  Occult breast carcinoma--use of color Doppler in localization.

Authors:  W J Lee; J S Chu; K J Chang; K M Chen
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Occult primary breast cancer at a comprehensive cancer center.

Authors:  Oluwadamilola M Fayanju; Donna B Jeffe; Julie A Margenthaler
Journal:  J Surg Res       Date:  2013-07-02       Impact factor: 2.192

9.  The role of sonography in patients with breast cancer presenting as an axillary mass.

Authors:  Sun Young Park; Eun-Kyung Kim; Ki Keun Oh; Kyong Sik Lee; Byeong-Woo Park
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

10.  Clinicopathologic characteristics of malignant non-hematopoietic tumors first presented as an axillary mass with emphasis on occult breast carcinoma.

Authors:  Thaer Khoury; Ana Lucia Ruano Mendez; Xuan Peng; Li Yan; Emilian Racila
Journal:  Int J Clin Oncol       Date:  2019-10-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.